Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
CDGSH iron sulfur domain 2 | 0.590 | 0.692 | 0.42 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
biotinidase | 0.628 | 0.654 | 1.5E-07 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
myosin IA | 0.769 | 0.269 | 8.9E-46 |
|
phenotype | 0.300 | limited | 0 | 0 | |||||||||||
|
paired like homeodomain 2 | 0.489 | 0.808 | 0.98 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
arylsulfatase B | 0.595 | 0.692 | 7.0E-09 |
|
phenotype | 0.400 | None | 0 | 0 | |||||||||||
|
abhydrolase domain containing 5 | 0.641 | 0.538 | 6.4E-07 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
transmembrane inner ear | 0.890 | 0.115 | 7.7E-05 |
|
phenotype | 0.410 | strong | < 0.001 | 0 | 0 | 2006 | 2006 | ||||||||
|
forkhead box C1 | 0.483 | 0.846 | 0.95 |
|
phenotype | 0.410 | strong | 0.500 | 1 | 0 | 2004 | 2013 | ||||||||
|
SIX homeobox 1 | 0.496 | 0.692 | 0.65 |
|
phenotype | 0.420 | strong | 0.667 | 1 | 0 | 1998 | 2011 | ||||||||
|
lipoxygenase homology domains 1 | 0.792 | 0.231 | 5.6E-26 |
|
phenotype | 0.320 | strong | 0.667 | 1 | 0 | 2012 | 2018 | ||||||||
|
grainyhead like transcription factor 2 | 0.590 | 0.731 | 1.00 |
|
phenotype | 0.330 | strong | 0.750 | 1 | 0 | 2008 | 2019 | ||||||||
|
transmembrane channel like 1 | 0.769 | 0.346 | 9.2E-19 |
|
phenotype | 0.450 | strong | 0.833 | 1 | 0 | 2004 | 2015 | ||||||||
|
gasdermin E | 0.656 | 0.423 | 3.3E-09 |
|
phenotype | 0.570 | strong | 0.875 | 1 | 0 | 1998 | 2012 | ||||||||
|
cochlin | 0.659 | 0.385 | 1.2E-07 |
|
phenotype | 0.400 | strong | 0.909 | 1 | 0 | 1999 | 2019 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
phenotype | 0.500 | moderate | 0.931 | 1 | 0 | 1998 | 2019 | ||||||||
|
gap junction protein beta 2 | 0.441 | 0.846 | 6.6E-16 |
|
phenotype | 0.500 | strong | 0.968 | 1 | 0 | 1998 | 2019 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1992 | 2006 | ||||||||
|
polyribonucleotide nucleotidyltransferase 1 | 0.653 | 0.462 | 4.0E-04 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
phenotype | 0.400 | strong | 1.000 | 2 | 0 | 1996 | 2006 | ||||||||
|
serpin family B member 6 | 0.547 | 0.769 | 1.1E-04 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
ATPase H+ transporting V1 subunit B1 | 0.695 | 0.346 | 2.4E-09 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
phenotype | 0.700 | strong | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
myosin XVA | 0.722 | 0.346 | 1.3E-56 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 1998 | 2019 |